Agenda

Ninth Central European Life Science Investment Conference
Hotel Stary, Krakow, 16-18 October 2019

This year’s top level theme:
“Do Darwinian principles apply to the biotech industry?”

Agenda correct on
7 October 2019

16 October 2019
18.00 - 20.00	Registration open
18.00	Pre-conference Drinks Reception at the Hotel Stary Wine from the Fantastic View and Jagiellonian University vineyards (Poland)
17 October 2019 MAIN CONFERENCE STARTS
8.00	Registration Open
9.00	Opening session: Darwinian forces in the Business of Biotechnology
9.00	Opening Remarks Roland Kozlowski, LSBC(London), United Kingdom
9.15	Talk: Forces for change, DaDa, Bowie and Biotechnology Anthony Sedgwick, Thought Disruptor, United Kingdom
10.00	Talk: Is Change Management a Darwinian process? Andrew Skowronski, A&C Associates, Singapore
10:45	Coffee & Networking
11:30	Technology Transfer
11.30	Panel: Compare and contrast technology transfer in developing and mature markets Chair: Dariusz Wiatr, Business Angel, USA / Poland Leszek Grabarczyk, Audere Group, Poland Mikołaj Gurdała, EIT Health InnoStars, Hungary David Vita, Redbreek Fund, Israel Michał Gwizda, Crido, Poland
12.15	Company Presentations Bioceltix Sp. z o.o. Poland Simplicardiac sp. z o.o., Poland HiProMine S.A., Poland
13.00 - 14.00	Networking lunch
14.00	Session: Financing Chair: Stefan Ogrodziński
14.00	Panel: The funding gap: “kiss of death or natural selection?” Stefan Ogrodziński, OncoTherics Limited, United Kingdom Mikołaj Gurdała, EIT Health InnoStars, Hungary Ronald Landes, Von Baer Wolff, USA Pawel Wielgus, Kvarko, Poland Robert Watson, Gyrus Capital, Switzerland Sanjeev Choudhary, Medinice, Poland
14.45	Panel: Listing - a fund raising or exit event comparing developing and mature markets Chair: Tania Fernandez, Dreamcatcher Ventures, USA Paweł Przewięźlikowski, Ryvu Therapeutics S.A., Poland John Bason, PFR, Poland Artur Chabowski, Lipid Systems, Poland Marcin Szuba, Lartiq, Poland Steven Powell, eTheRNA, United Kingdom
15.30 - 16.15	TEA & Networking
16.15 - 17.00	Session: Management Issues
16.15	Panel: Will the polish biotech and associated investment industry succeed without experienced management? Chair: Matthew Tabeau, Proteon, Poland Karolina Jarosińska, ExecMind, Poland Paul Edwards, Horton International, United Kingdom John Borg, EMA, Malta Mariusz Olejniczak, WPD Pharmaceuticals sp. z o.o. Tracy Weightman, Bridge Valley Ventures, United Kingdom
17.00	Open discussion from the floor and conference close for the day
19:30	Networking drinks, Wine Tasting, Conference Dinner & Live Music: Restaurant Pod Różą Wine from the Fantastic View and Jagiellonian University Vineyards (Poland)
18 October 2018
9.30	Session: Company Presentations
9.30	Cellese Limited, United Kingdom Captor Therapeutics S.A., Poland DEBN Sp. z o.o., Poland Medinice SA, Poland OncoTherics Limited., United Kingdom Orion Biotechnology Polska Sp. z o.o., Poland Pharmacann Sp zo.o. Poland Wheelstair Sp z o.o., Poland
11.00	Coffee & Networking
12.00	Preparing for the Future
12.00	Talk: Low capital intensity biotech: a better way forward for the CE region? Chair: Mark Treherne, Cellese, United Kingdom Marek Borzestowski, Giza Polish Ventures, Poland Dominik Ziętkowski, Blirt, Poland Fillip Jeleń, Captor Therapeutics S.A., Poland Francois Mereau, Mereau Partners, France Artur Chabowski, Lipid Systems, Poland
12.45	Brainstorm panel / Open session: “predicting the future” Panelists: Five participants chosen from conference attendees over dinner who have something bold they would like to raise! Themes taken from earlier panels and talks. Chair: Roland Kozlowski, LSBC (London) Limited, UK
13.15	Summing up and Conference Close Roland Kozlowski

LSBC